CYPC19*17 Allele May Influence Response to PPI Treatment

This article originally appeared here.
Share this content:
<i>CYPC19&#42;17</i> Allele May Influence Response to PPI Treatment
CYPC19*17 Allele May Influence Response to PPI Treatment

TUESDAY, Sept. 26, 2017 (HealthDay News) -- Children with CYP2C19*17 alleles without corresponding loss-of-function alleles have longer times with pH <4 in response to proton pump inhibitor (PPI) medication, according to a study published online Sept. 8 in the Journal of Clinical Pharmacology.

James P. Franciosi, M.D., Ph.D., from the Nemours Children's Hospital in Orlando, Fla., and colleagues examined whether pH probe acid exposure outcomes are associated with CYP2C19*17 alleles among children with clinical concern for gastroesophageal reflux. A retrospective cohort of 74 children with stored endoscopic tissue samples were identified; they had also undergone esophageal pH testing while on PPI therapy. After genotyping, these individuals were dichotomized to CYP2C19*17 allelic carriers without corresponding loss-of-function alleles as cases, versus controls.

The researchers found that children who carry CPY2C19*17 alleles without corresponding loss-of-function alleles demonstrated significantly longer times with pH <4 compared to controls (76.46 versus 33.47 minutes; P = 0.03); they also had a higher percent of time with pH <4 (5.71 versus 2.67 minutes; P = 0.04). Using multiple-regression modeling with test duration, PPI dose, and race as confounding variables, these findings remained statistically significant.

"We conclude that the CYP2C19*17 allele may influence response to PPI medication therapy in children, and PPI therapy may be better optimized with genotype-guided dosing," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Disease-carrying ticks were detected in 83 counties where they'd never been found before

Availability of Generic Antivirals for Hepatitis B Increasing

Availability of Generic Antivirals for Hepatitis B Increasing

Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016

Visual Function Deficits Up in Developmental Dyslexia

Visual Function Deficits Up in Developmental Dyslexia

Increased prevalence of deficits in visual function versus typically developing school-age children

is free, fast, and customized just for you!




Already a member?

Sign In Now »